415 related articles for article (PubMed ID: 22186140)
1. miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.
Huang G; Nishimoto K; Zhou Z; Hughes D; Kleinerman ES
Cancer Res; 2012 Feb; 72(4):908-16. PubMed ID: 22186140
[TBL] [Abstract][Full Text] [Related]
2. miR-20a Regulates FAS Expression in Osteosarcoma Cells by Modulating
Yang Y; Huang G; Zhou Z; Fewell JG; Kleinerman ES
Mol Cancer Ther; 2018 Jan; 17(1):130-139. PubMed ID: 29079708
[TBL] [Abstract][Full Text] [Related]
3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
4. Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.
Huang G; Nishimoto K; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2014; 804():203-17. PubMed ID: 24924176
[TBL] [Abstract][Full Text] [Related]
5. VEGF165 is necessary to the metastatic potential of Fas(-) osteosarcoma cells but will not rescue the Fas(+) cells.
Jia SF; Guan H; Duan X; Kleinerman ES
J Exp Ther Oncol; 2008; 7(2):89-97. PubMed ID: 18771083
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase inhibitor, MS-275 (entinostat), downregulates c-FLIP, sensitizes osteosarcoma cells to FasL, and induces the regression of osteosarcoma lung metastases.
Rao-Bindal K; Koshkina NV; Stewart J; Kleinerman ES
Curr Cancer Drug Targets; 2013 May; 13(4):411-22. PubMed ID: 23410027
[TBL] [Abstract][Full Text] [Related]
7. Increased Fas expression reduces the metastatic potential of human osteosarcoma cells.
Lafleur EA; Koshkina NV; Stewart J; Jia SF; Worth LL; Duan X; Kleinerman ES
Clin Cancer Res; 2004 Dec; 10(23):8114-9. PubMed ID: 15585647
[TBL] [Abstract][Full Text] [Related]
8. Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine.
Gordon N; Kleinerman ES
J Aerosol Med Pulm Drug Deliv; 2010 Aug; 23(4):189-96. PubMed ID: 20528149
[TBL] [Abstract][Full Text] [Related]
9. The role of Fas/FasL in the metastatic potential of osteosarcoma and targeting this pathway for the treatment of osteosarcoma lung metastases.
Gordon N; Kleinerman ES
Cancer Treat Res; 2009; 152():497-508. PubMed ID: 20213411
[TBL] [Abstract][Full Text] [Related]
10. PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma.
Hirahata M; Osaki M; Kanda Y; Sugimoto Y; Yoshioka Y; Kosaka N; Takeshita F; Fujiwara T; Kawai A; Ito H; Ochiya T; Okada F
Cancer Med; 2016 May; 5(5):892-902. PubMed ID: 26817521
[TBL] [Abstract][Full Text] [Related]
11. Fas-negative osteosarcoma tumor cells are selected during metastasis to the lungs: the role of the Fas pathway in the metastatic process of osteosarcoma.
Koshkina NV; Khanna C; Mendoza A; Guan H; DeLauter L; Kleinerman ES
Mol Cancer Res; 2007 Oct; 5(10):991-9. PubMed ID: 17951400
[TBL] [Abstract][Full Text] [Related]
12. Fas expression in metastatic osteosarcoma cells is not regulated by CpG island methylation.
Huang G; Koshkina NV; Kleinerman ES
Oncol Res; 2009; 18(1):31-9. PubMed ID: 19911702
[TBL] [Abstract][Full Text] [Related]
13. Corruption of the Fas pathway delays the pulmonary clearance of murine osteosarcoma cells, enhances their metastatic potential, and reduces the effect of aerosol gemcitabine.
Gordon N; Koshkina NV; Jia SF; Khanna C; Mendoza A; Worth LL; Kleinerman ES
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4503-10. PubMed ID: 17671136
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling identifies MiR-195 suppresses osteosarcoma cell metastasis by targeting CCND1.
Han K; Chen X; Bian N; Ma B; Yang T; Cai C; Fan Q; Zhou Y; Zhao TB
Oncotarget; 2015 Apr; 6(11):8875-89. PubMed ID: 25823925
[TBL] [Abstract][Full Text] [Related]
15. Association of alphavbeta3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells.
Duan X; Jia SF; Zhou Z; Langley RR; Bolontrade MF; Kleinerman ES
Clin Exp Metastasis; 2004; 21(8):747-53. PubMed ID: 16035619
[TBL] [Abstract][Full Text] [Related]
16. miRNA-20a upregulates TAK1 and increases proliferation in osteosarcoma cells.
Yuan G; Zhao Y; Wu D; Gao C; Jiao Z
Future Oncol; 2018 Feb; 14(5):461-469. PubMed ID: 29327611
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MALAT1 facilitates lung metastasis of osteosarcomas through miR-202 sponging.
Zhang J; Piao CD; Ding J; Li ZW
Sci Rep; 2020 Jul; 10(1):12757. PubMed ID: 32728178
[TBL] [Abstract][Full Text] [Related]
18. The Role of FAS Receptor Methylation in Osteosarcoma Metastasis.
Sun JM; Chow WY; Xu G; Hicks MJ; Nakka M; Shen J; Ng PKS; Taylor AM; Yu A; Farrar JE; Barkauskas DA; Gorlick R; Guidry Auvil JM; Gerhard D; Meltzer P; Guerra R; Man TK; Lau CC; On Behalf Of The Target Osteosarcoma Consortium
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569529
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of pro-angiogenic molecules and events does not relate with an angiogenic switch in metastatic osteosarcoma cells but to cell survival features.
Gutiérrez LM; Valenzuela Alvarez M; Yang Y; Spinelli F; Cantero MJ; Alaniz L; García MG; Kleinerman ES; Correa A; Bolontrade MF
Apoptosis; 2021 Aug; 26(7-8):447-459. PubMed ID: 34024019
[TBL] [Abstract][Full Text] [Related]
20. MiR-511 mimic transfection inhibits the proliferation, invasion of osteosarcoma cells and reduces metastatic osteosarcoma tumor burden in nude mice via targeting MAPK1.
Wu J; Zhang C; Chen L
Cancer Biomark; 2019; 26(3):343-351. PubMed ID: 31524148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
